The Alcohol Clinical Trials Initiative (ACTIVE): Purpose and Goals for Assessing Important and Salient Issues for Medications Development in Alcohol Use Disorders

[1]  M C Neale,et al.  Alcoholism and major depression in women. A twin study of the causes of comorbidity. , 1993, Archives of general psychiatry.

[2]  David Couper,et al.  Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. , 2006, JAMA.

[3]  D. Ciraulo,et al.  Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial. , 2008, Archives of internal medicine.

[4]  B. Rounsaville,et al.  Naltrexone and coping skills therapy for alcohol dependence. A controlled study. , 1992, Archives of general psychiatry.

[5]  H. Kranzler,et al.  Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. , 2005, JAMA.

[6]  H. S. Davis,et al.  A Controlled Study , 1966 .

[7]  N. O'mara,et al.  Naltrexone in the treatment of alcohol dependence. , 1994, The Annals of pharmacotherapy.

[8]  J. Farrar,et al.  Core outcome measures for chronic pain clinical trials: IMMPACT recommendations , 2003, Pain.

[9]  H. Kranzler,et al.  Efficacy and Tolerability of Long-Acting Injectable Naltrexone for Alcohol DependenceA Randomized Controlled Trial , 2005 .

[10]  Jürgen Rehm,et al.  Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders , 2009, The Lancet.

[11]  R. Rosenheck,et al.  Naltrexone in the treatment of alcohol dependence. , 2001, The New England journal of medicine.

[12]  J. Farrar,et al.  Core outcome domains for chronic pain clinical trials: IMMPACT recommendations , 2003, Pain.

[13]  Michael F. Green,et al.  A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. , 2005, Schizophrenia bulletin.

[14]  A. Zweben,et al.  Development of a composite measure for assessing alcohol treatment outcome: operationalization and validation. , 1999, Alcoholism, clinical and experimental research.

[15]  Elizabeth L. Ogburn,et al.  Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. , 2007, Archives of general psychiatry.

[16]  H. Skinner,et al.  Alcohol Dependence Scale , 2012 .

[17]  A. Zweben,et al.  Clinical and methodological utility of a composite outcome measure for alcohol treatment research. , 2003, Alcoholism, clinical and experimental research.

[18]  K. Levit,et al.  Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty. , 2009, Drug and alcohol dependence.

[19]  D. Ciraulo,et al.  Topiramate for treating alcohol dependence: a randomized controlled trial. , 2007, JAMA.

[20]  W. Miller,et al.  The Drinker Inventory of Consequences (DrInC) , 1995 .

[21]  M. Mundt,et al.  Carbohydrate-deficient transferrin: validity of a new alcohol biomarker in a sample of patients with diabetes and hypertension. , 2004, The Journal of the American Board of Family Practice.

[22]  K. Bucholz,et al.  Periods of abstinence following the onset of alcohol dependence in 1,853 men and women. , 1997, Journal of studies on alcohol.

[23]  P. Miller,et al.  Biochemical alcohol screening in primary health care. , 2004, Addictive behaviors.

[24]  P. Miller,et al.  Blood pressure reduction during treatment for alcohol dependence: results from the Combining Medications and Behavioral Interventions for Alcoholism (COMBINE) study. , 2008, Addiction.

[25]  L. Sobell,et al.  The reliability of the Alcohol Timeline Followback when administered by telephone and by computer. , 1996, Drug and alcohol dependence.

[26]  H. Kranzler,et al.  A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Aripiprazole for the Treatment of Alcohol Dependence , 2008, Journal of clinical psychopharmacology.

[27]  L C Sobell,et al.  Reliability of a timeline method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations. , 1988, British journal of addiction.